These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3314259)

  • 61. Discrimination of Human Pathogen Clostridium Species Especially of the Heterogeneous C. sporogenes and C. botulinum by MALDI-TOF Mass Spectrometry.
    Schaumann R; Dallacker-Losensky K; Rosenkranz C; Genzel GH; Stîngu CS; Schellenberger W; Schulz-Stübner S; Rodloff AC; Eschrich K
    Curr Microbiol; 2018 Nov; 75(11):1506-1515. PubMed ID: 30120528
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modification of an acetone-sodium dodecyl sulfate disruption method for cellular protein extraction from neurotoxigenic Clostridium botulinum.
    Bhaduri S
    Foodborne Pathog Dis; 2012 Feb; 9(2):172-4. PubMed ID: 22044259
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Infect Immun; 1976 Mar; 13(3):855-60. PubMed ID: 773828
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serological classification and typing of Clostridium botulinum.
    Giménez DF
    Dev Biol Stand; 1976; 32():175-83. PubMed ID: 793913
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Insoluble antigens in the identification of Cl. botulinum. 3. Chemical studies of polysaccharides].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):65-83. PubMed ID: 4596012
    [No Abstract]   [Full Text] [Related]  

  • 66. [Studies of type F Clostridium botulinum. IV. Serological properties of soluble and insoluble antigens].
    Rymkiewicz D
    Med Dosw Mikrobiol; 1970; 22(1):13-20. PubMed ID: 4986009
    [No Abstract]   [Full Text] [Related]  

  • 67. Prevalence and diversity of Clostridium botulinum types A, B, E and F in honey produced in the Nordic countries.
    Nevas M; Lindström M; Hautamäki K; Puoskari S; Korkeala H
    Int J Food Microbiol; 2005 Nov; 105(2):145-51. PubMed ID: 16054259
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro evaluation methods for Clostridium botulinum type C and D vaccines.
    Ellis CE; Hamman M; Harris H; de Bruin R
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):369-72. PubMed ID: 10397324
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains.
    Krieglstein KG; DasGupta BR; Henschen AH
    J Protein Chem; 1994 Jan; 13(1):49-57. PubMed ID: 8011071
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Proteases of Clostridium botulinum. V. Studies on the serological relationship between proteases from Clostridium botulinum and other spore-forming bacteria.
    Tjaberg TB; Fossum K
    Acta Vet Scand; 1973 May; 14(5):700-11. PubMed ID: 4359093
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantitative chemical analyses and antigenic properties of peptidoglycans from Clostridium botulinum and other clostridia.
    Takumi K; Kawata T
    Jpn J Microbiol; 1976 Aug; 20(4):287-92. PubMed ID: 62070
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Studies on the soluble antigens of Clostridium oedematiens (Cl. novyi).
    Rutter JM; Collee JG
    J Med Microbiol; 1969 Nov; 2(4):395-417. PubMed ID: 5408516
    [No Abstract]   [Full Text] [Related]  

  • 74. Electron capture gas chromatography study of the acid and alcohol products of Clostridium septicum and Clostridium chauvoei.
    Brooks JB; Selin MJ; Alley CC
    J Clin Microbiol; 1976 Feb; 3(2):180-5. PubMed ID: 1254716
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Purification and properties of boticin P produced by Clostridium botulinum.
    Lau AH; Hawirko RZ; Chow CT
    Can J Microbiol; 1974 Mar; 20(3):385-90. PubMed ID: 4132521
    [No Abstract]   [Full Text] [Related]  

  • 76. Numerical taxonomy of Clostridium botulinum and Clostridium sporogenes strains, and their susceptibilities to induced lysins and to mitomycin C.
    Kiritani K; Mitsui N; Nakamura S; Nishida S
    Jpn J Microbiol; 1973 Sep; 17(5):361-72. PubMed ID: 4587762
    [No Abstract]   [Full Text] [Related]  

  • 77. Purification and characterization of Clostridium botulinum type B oxin.
    Gerwing J; Dolman CE; Kason DV; Tremaine JH
    J Bacteriol; 1966 Feb; 91(2):484-7. PubMed ID: 5327476
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Various results of the study on antigenic differences between Clostridium sordellii and Clostridium bifermentans].
    Egorova GK; Fedorov IuM; Bocharova NG
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):138. PubMed ID: 665020
    [No Abstract]   [Full Text] [Related]  

  • 79. [Immunochemical and biological characteristics of type A botulinum toxoids. II].
    Drachennikov VI; Golshmid VK; Rezepov FF; Chentsova OI
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):12-8. PubMed ID: 4941809
    [No Abstract]   [Full Text] [Related]  

  • 80. Biochemical classification of Clostridium botulinum type C and D strains and their nontoxigenic derivatives.
    Oguma K; Yamaguchi T; Sudou K; Yokosawa N; Fujikawa Y
    Appl Environ Microbiol; 1986 Feb; 51(2):256-60. PubMed ID: 3513703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.